H. Golding et al., PHORBOL ESTER-INDUCED DOWN-MODULATION OF TAILLESS CD4 RECEPTORS REQUIRES PRIOR BINDING OF GP120 AND SUGGESTS A ROLE FOR ACCESSORY MOLECULES, Journal of virology, 69(10), 1995, pp. 6140-6148
The entry of human immunodeficiency virus type 1 into cells proceeds v
ia a fusion mechanism that is initiated by binding of the viral glycop
rotein gp120-gp41 to its cellular receptor CD4. Species- and tissue-sp
ecific restrictions to viral entry suggested the participation of addi
tional membrane components in the postbinding fusion events. In a prev
ious study (H. Golding, J. Manischewitz, L. Vujcic, R. Blumenthal, and
D. Dimitrov, J. Virol. 68:1962-1968, 1994), it was found that phorbol
myristate acetate (PMA) inhibits human immunodeficiency virus type 1
envelope-mediated cell fusion by inducing down modulation of an access
ory component(s) in the CD4 expressing cells. The fusion inhibition wa
s seen in a variety of cells, including T-cell transfectants expressin
g engineered CD4 receptors (CD4.401 and CD4.CD8) which are not suscept
ible to down modulation by PMA treatment. In the current study, it was
found that preincubation of A2.01.CD4.401 cells with soluble monomeri
c gp120 for 1 h at 37 degrees C primed them for PMA-induced down modul
ation (up to 70%) of the tailless CD4 receptors. The gp120-priming eff
ect was temperature dependent, and the down modulation may have occurr
ed via clathrin-coated pits. Importantly, nonhuman cell lines expressi
ng tailless CD4 molecules did not down modulate their CD4 receptors un
der the same conditions. The gp120-dependent PMA-induced down modulati
on of tailless CD4 receptors could be efficiently blocked by the human
monoclonal antibodies 48D and 17B, which bind with increased avidity
to gp120 that was previously bound to CD4 (M. Thali, J. P. Moore, C. F
urman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski, J. Virol. 6
7:3978-3988, 1993). These findings suggest that gp120 binding to cellu
lar CD4 receptors induces conformational changes leading to associatio
n of the gp120-CD4 complexes with accessory transmembrane molecules th
at are susceptible to PMA-induced down modulation and can target the v
irions to clathrin-coated pits.